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The interleukin-17 (IL-17) family of cytokines phylo-
genetically predates the evolution of T cells in jawed
vertebrates, suggesting that the ontogeny of the
Th17 cell lineagemust have arisen to confer an evolu-
tionary advantage to the host over innate sources of
IL-17. Utilizing amodel of mucosal immunization with
the encapsulated bacteria Klebsiella pneumoniae,
we found that B cells, which largely recognized
polysaccharide capsular antigens, afforded protec-
tion to only the vaccine strain. In contrast, memory
Th17 cells proliferated in response to conserved
outer membrane proteins and conferred protection
against several serotypes of K. pneumoniae, in-
cluding the recently described multidrug resistant
New Dehli metallolactamase strain. Notably, this
heterologous, clade-specific protection was anti-
body independent, demonstrating the Th17 cell
lineage confers a host advantage by providing heter-
ologousmucosal immunity independent of serotype-
specific antibody.
INTRODUCTION
The interleukin-17 (IL-17) family of cytokines is evolutionarily
conserved with IL-17D having orthologs in Ciona intestinalis
and mollusks (Roberts et al., 2008). IL-17A, often referred as
IL-17, and IL-17F, the two isoforms expressed in memory Th17
cells (Weaver et al., 2007; Khader et al., 2009; Dong, 2008), arose
concomitantly with T cells in jawed vertebrates and mammals
(Guo et al., 2009). Two effector cytokines expressed by Th17
cells, IL-17 and IL-22, have been thought to play key roles in
mucosal immunity primarily to extracellular pathogens. IL-17
regulates the expression of G-CSF, granulopoiesis, andmucosal
CXC chemokines important in neutrophil recruitment (Khader
et al., 2009). IL-22 increases barrier function of the epithelium,
synergizes with IL-17 in the expression of mucosal chemokines,
and induces the expression of antimicrobial peptides (Aujla et al.,
2008; Zheng et al., 2008). However, this model does not clearly
explain why memory Th17 cells, instead of local mucosal struc-
tural cells such as fibroblasts or epithelial cells, evolved to beIma critical source of these cytokines. Theoretically, the advantage
of T cell encoded IL-17 and IL-22 could be threefold: (1) T cells
can rapidly divide and undergo apoptosis, providing a mecha-
nism for rapid amplification and termination of the Th17 re-
sponse; (2) T cells can traffic to and from mucosal sites to
provide immune reconnaissance; and (3) The generation of
memory Th17 cells might confer an advantage to the host above
and beyond what a pathogen-specific antibody can provide.
This latter hypothesis is attractive because extracellular patho-
gens such as Klebsiella pneumoniae and Streptococcus pneu-
moniae have evolved to rapidly change their capsular polysac-
charide to avoid a host-specific antibody (Weinberger et al.,
2010; Malley, 2010; Kohler et al., 2007; Podschun and Ullmann,
1998).
To investigate the roles of Th17 cells in vaccine-induced
immunity, we employed a model of pulmonary infection with
the encapsulated gram-negative pathogen K. pneumoniae.
Immunizing mice with heat-killed K. pneumoniae organisms
generated a substantial pool of Th17 cells in lung mucosa and
also elicited a robust antibody response against capsular poly-
saccharides. Although the antibody response was effective at
reducing bacterial burden within the vaccine strain, it afforded
little protection against heterologous K. pneumoniae isolates
with distinct polysaccharide serotypes. Th17 cells were found
to be the critical CD4 T cell population required for immunity
to heterologous K. pneumoniae strains. We provide evidence
that outer membrane proteins (OMPs) conserved across several
serotypes of K. pneumoniae are responsible for antigen-specific
Th17 cell priming in mediastinal lymph nodes during vaccination,
resulting in long-term protection against strains that are not
effectively neutralized by antibodies. Thus, our findings illustrate
that Th17 cells can provide clade-specific, serotype-indepen-
dent immunity against bacteria, suggesting a possible evolu-
tionary advantage for the acquisition of IL-17 expression by
CD4 T cell subsets.
RESULTS
Intranasal Immunization Induces Robust Mucosal Th17
Response
Figure 1A shows a radial cladogram of IL-17A, IL-17D, and
IL-17F protein families from different organisms, including
mammal, bird, fish, frog,Ciona intestinalis, and oyster, indicating
that existence of the gene predates the development of adaptivemunity 35, 997–1009, December 23, 2011 ª2011 Elsevier Inc. 997
Figure 1. Immunization with Heat-Killed K. pneumoniae Induces Antigen-Specific Th17 Responses
(A) Radial cladogram of IL-17A(A), IL-17D, IL-17F protein families from different organisms including mammal (dark blue), bird (red), fish (sky blue), frog (pink),
C. intestinalis (lime), and oyster (green). The following abbreviations are used: Hs, Homo sapiens; Mm, Mus musculus; Bt, Bos Taurus; Rn, Rattus norvegicus;
Ss, Sus scrofa; Ec, Equus caballus; Md,Monodelphis domestica; Ol, Oryzias latipes; Sr, Salmo salar; Tr, Takifugu rubripes; Dr, Danio rerio; Gg, Gallus gallus; Ci,
Ciona intestinalis; Xt, Xenopus tropicalis; Cg, Crassostrea gigas.
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Th17 Cells and Clade-Specific ImmunityT cell immunity (Figure 1A). Orthologs of IL-17A and IL-17F arise
with lower jawed vertebrates and track closely with the evolution
of T cells and recombinase-activating genes, suggesting an
evolutionary advantage of T cell-encoded IL-17A and IL-17F
(Figure 1A). To test the role of memory Th17 cells in mucosal
immunity, we developed a method to generate robust memory
Th17 cell responses. C57BL/6 mice were immunized intranasally
with 20 mg of heat-killed K. pneumoniae-43816 (ATCC) on day
0 and day 7 and then sacrificed on day 14 to assess T cell
responses in the lung. Intracellular cytokine staining showed
that immunization substantially increased the numbers of Th17
(IL-17+) and Th22 (IL-22+) cells in the lung but only moderately
increased Th1 cell numbers (IFN-g+) (Figures 1B and 1C). Further
analysis of IL-17+ cells revealed that although gd-T cells were the
major source of IL-17 during primary infection, CD4+ T cells were
primarily responsible for the increased IL-17+ cell population
observed following immunization (Figure 1B, lower panel). These
results were confirmed with IL-17F-Thy1.1 reporter mice (Fig-
ure 1D) (Lee et al., 2009) RT-PCR and flow cytometry analysis
also identified Vg4 (Heilig naming system) as the major subtype
of IL-17-producing gd-T cells (Figures S1A and S1B, available
online), consistent with previous findings in an autoimmune
disease model (Martin et al., 2009; Sutton et al., 2009). To further
characterize IL-17-producing cells induced by primary infec-
tion versus immunization, we sorted Thy1.1+ cells on the basis
of surface expression of gd-TCR (naive mice, termed GD17), or
CD4 (immunized mice, termed Th17). In addition, we sorted
Thy1.1CD4+ cells (immunized mice, termed Th-non-IL17F).
Real-time PCR analysis confirmed that both GD17 cells and
Th17 cells expressed high amounts of Il17 and Il22 (Figure 1E),
whereas only Th17 cells expressed Il21. Genes that are critical
for Th17 cell induction or function, such as Rorc, Ahr, Ccr6,
Il1r1, and Il23r, were highly expressed in both GD17 and Th17
cell lineages (Figures S1D and S1E) (Weaver et al., 2007; Chung
et al., 2009). When cultured with different species of heat-killed
gram-positive or gram-negative bacteria, Th17 cells were
only capable of responding to K. pneumoniae-43816 (ATCC) re-
stimulation, producing microgram quantities of IL-17 in culture
supernatants (Figures 1F and 1G). This demonstrated the immu-
nization-induced Th17 cells were antigen specific. To further
support this, equal numbers of sorted GD17 and Th17 cell were
cultured with heat-killed K. pneumoniae-43816 (ATCC) Th17
cells but not GD17 cells; cells responded to K. pneumoniae-
43816 (ATCC) restimulation and produced IL-17 in the presence
or absence of neutralizing antibodies against IL-1b and IL-23
(Figure S1F), indicating the antigen-specific memory Th17 cell
recall response occurred independently of IL-1b and IL-23.(B) C57BL/6 mice were immunized intranasally with 20 mg heat-killed K. pneumo
Naivemice were sacrificed 24 hr after 104 liveK. pneumoniae-43816 (ATCC) (sero
intracellular cytokine staining (upper panel). Subsets of IL-17 producing cells wer
(C) Frequencies (left panel) and total numbers (right panel) of CD4 gated IFN-g, IL
each group.
(D) IL-17F-Th1.1 reporter mice were treated as in (B) and mononuclear cells in th
(E) Flow-cytometry-sorted splenic CD4+CD44lo (naive CD4), splenic CD3+GL3+
extracted. Transcripts of cytokines were measured by real-time RT-PCR. Data r
(F) Flow-cytometry-sorted Th17 from reporter mice were cultured with heat-kill
splenocytes as APC for 4 days, and responding Th17 cells were analyzed by sta
(G) IL-17A released into the medium was measured by Luminex (left panel) and to
mice of each group.
ImTo further characterize the T cell responses induced by immu-
nization, we immunized and sacrificed mice at various time
points and collected tissue from different organs to analyze
Th1 (IFN-g+CD4+) and Th17 (IL-17A+CD4+) cells by flow cytom-
etry. Representative flow cytometry plots from the spleen
(Figure 2A) showed that frequencies of Th17 (IL-17A+) cells
increased at weeks 1 and 2 after heat-killed K. pneumoniae-
43816 (ATCC) immunization and contracted at week 4, whereas
frequencies of Th1 (IFN-g+) cells remained constant following
immunization. Representative flow cytometry plots from the
lung and mediastinal lymph nodes showed similar staining
pattern and there were very few IFN-g-IL-17A double-positive
cells (Figure S1B). To further characterize these Th1 and Th17
cells, intracellular staining of T-bet and Rorgt was performed
(Figure 2B). Th17 cells showed a transient increase in T-bet
expression at weeks 1 and 2 after immunization, consistent
with previous report showing Th17 cells can upregulate T-bet
when stimulated with IL-12 (Lee et al., 2009). However, Rorgt
was strictly expressed by Th17 cells. Analysis of Th1 and Th17
cell numbers in the lung, spleen, and mediastinal lymph nodes
(mLN) (Figure 2C) and total numbers from all three organs (Fig-
ure 2D) revealed that Th17 cells activated and expanded at
weeks 1 and 2 and contracted at week 4, whereas the Th1 cell
response did not follow this pattern. Immunization had a minimal
effect on Th1 cells; a significant increase was observed only in
mediastinal lymph nodes after 1 week, suggesting that Th17
but not Th1 cells are strongly induced and may be more impor-
tant in this extracellular bacterial infection model.
Protection in an Autologous Challenge Model Is
Mediated by Antibody and Th17 Cell Effector Cytokines
To evaluate the protective efficacy of immunization against
subsequent pathogen challenge, C57BL/6 mice were immu-
nized and then challenged with 104 colony-forming units (CFUs)
of the autologous K. pneumoniae-43816 (ATCC) 4 weeks later.
Immunized animals showed a two-log lower bacterial burden
after challenge (Figure 3A). Almost half of the immunized animals
had sterile spleens when challenged, showing that mucosal
immunization is very effective in controlling local infection
and systemic dissemination. To examine the contributions of
IL-17A and IL-22 in the protection by immunization, we adminis-
tered neutralizing antibodies against IL-17A (Fei et al., 2011) and/
or IL-22 (Aujla et al., 2008) after immunization and prior to chal-
lenge with live K. pneumoniae-43816 (ATCC). In addition, some
mice were treated with 1A8 antibody to deplete neutrophils.
Despite the robust induction of memory Th17 cells, IL-17A,
IL-22, and neutrophils were dispensable for vaccine-inducedniae-43816 (ATCC) (serotype K2) at day 0 and day 7 and sacrificed on day 14.
type K2) infection. IL-17 and IL-22 producing cells in the lungs were analyzed by
e determined by analyzing CD4 and gd-TCR on IL-17 gated cells (lower panel).
-17A, and IL-22 producing cells. Data represent the mean ± SD of five mice of
e lung were analyzed by flow cytometry.
(spleen GD), nTh-non17F, GD17, and Th17 were lysed in TriZol and RNA was
epresent two independent experiments.
ed K. pneumoniae, E. coli, and S. aures in the presence of congenic CD45.1
ining congenic marker CD45.2 and CD4.
tal numbers were graphed (right panel). Data represent the mean ± SD of three
munity 35, 997–1009, December 23, 2011 ª2011 Elsevier Inc. 999
Figure 2. Characterization of Immunization-Induced T Cell Responses
C57BL/6 mice were immunized intranasally with 20 mg of heat-killed K. pneumoniae-43816 (ATCC) (serotype K2) at day 0 and sacrificed 1, 2, and 4 weeks after
lung, spleen, and mediastinal lymph nodes were collected and intracellular staining was performed. Each time point has a group of three mice.
(A) Representative flow cytometry plots of IL-17A and IFN-g staining on CD4 gated cells in the spleen.
(B) Representative flow cytometry plots of T-bet (upper panel) and Rorgt (lower panel) staining on IL-17A+ (Th17 blue line) and IFN-g+ (Th1 red line) from the
spleen. Mean fluorescent intensity of T-bet or Rorgt is shown on each plot.
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Th17 Cells and Clade-Specific Immunityprotection (Figure 3B), suggesting other mechanisms are
involved in the autologous protection.
We then postulated that humoral immunitymay be dominant in
this model because IL-17 has been shown to support antibody
responses (Mitsdoerffer et al., 2010). To determine whether B
cells and/or adaptive immunity are required for vaccine-induced
protection, we immunized Rag2/Il2rg/ mice, which lack T,
B, and NK cells, and infected them 4 weeks later. No protection
was observed in these mice (Figure 3C), suggesting that B cells
might play a protective role in wild-type mice. Measuring
K. pneumoniae-43816 (ATCC)-specific antibodies in serum and
lung homogenate by ELISA in wild-type mice confirmed that
immunized mice had substantial titers of K. pneumoniae-43816
(ATCC)-specific IgG and IgA in comparison to naive mice (Fig-
ure 3D). This antibody response induced by immunization was
not IL-17 dependent because immunized Il17ra/ mice had
amounts of anti-K. pneumoniae-43816 (ATCC) IgG in their lungs
that were similar to the amounts in the lungs of their wild-type
litter mate controls (Figure S2A). As a negative control, anti-
body concentrations from B cell-deficient (Ighm/) mice
were also measured (Figure S2A). CD4 depletion prior to
immunization did not affect the protection against this autolo-
gous K. pneumoniae-43816 (ATCC) challenge (Figure S2C).
Moreover, the anti-K. pneumoniae-43816 (ATCC) antibody
response was not affected in CD4-depleted mice, demon-
strating that the antibody response is T cell independent. (Fig-
ure S2D). Adoptive transfer of B cells from immunized mice
conferred protection in Rag2/Il2rg/ mice (Figure 3E), con-
firming that B cells are capable of mediating the protection to
a secondary autologous challenge.
To determine whether the generated Th17 cells could confer
protection independent of antibody, we immunized B cell-
deficient (Ighm/) mice. Immunized (Ighm/) mice still demon-
strated a one-log protection in the lung and spleen against
pulmonary bacterial challenge (Figure 3F and Figure S2B). To
examine whether this protection required Th17 cell effector cyto-
kines we administered anti-IL-17A or anti-Ly6g (1A8) immedi-
ately prior to the autologous bacterial challenge. In contrast to
wild-type mice, immunization in Ighm/ mice was dependent
on IL-17A and neutrophils (compare Figures 3B and 3F). These
results demonstrate that in the autologous challenge model, B
cells or antibodies confer primary protection, but IL-17A and
neutrophils confer secondary protection in the absence of
antibody.
Cross-Serotype Protection inHeterologousChallenge Is
Th17 Cell Dependent
Like many extracellular pathogens, K. pneumoniae species are
clades of organisms that have multiple capsular serotypes
(Petermann et al., 2010; Podschun and Ullmann, 1998). Thus,
we hypothesized that although antibody responses are domi-
nant in an autologous challenge model, an advantage of Th17
cells may be a broader serotype-independent immunity. To
investigate whether antibodies are protective against infection(C) Total numbers of Th1 (upper panel) and Th17 (lower panel) in lung, spleen, an
(D) Total numbers of Th1 and Th17 in three organs together were graphed. The as
the naive group.
Data in (C) and (D) represent the mean ± SD of three mice of each group.
Immfrom heterologous strains, we immunized mice with the
K. pneumoniae-43816 (ATCC) (serotype K2) strain and tested
antibody crossreactivity to clades of clinical isolates obtained
from Southeast Asia, where K. pneumoniae liver and lung
abscesses (Table S1) are endemic (Ho et al., 2010). The IgG anti-
body response in mice immunized with K. pneumoniae-43816
(ATCC) reacted only with K2 serotypes and not with K1 or K16
serotypes (Figure 4A). We observed no antibody crossreactivity
to different serotypes of K. pneumoniae, and only 2/3 of the K2
strains showed crossreactivity (Figure 4A), indicating that anti-
bodies were unlikely to confer protection against heterologous
serotypes. Serum from immunized mice killed only the autolo-
gous K. pneumoniae-43816 (ATCC) (serotype K2) and not the
heterologous K. pneumoniae-396 (serotype K1) isolate in vitro
(Figure S3A), further supporting that the B cell response is strain
specific.
Interestingly, local memory Th17 cells generated from
K. pneumoniae-43816 (ATCC) immunization demonstrated pro-
liferative responses to all serotypes of K. pneumoniae tested,
including the recently described New Delhi metallolactamase
(NDM-1+) strain (Yong et al., 2009) (Figure 4B). However, neither
S. pneumoniae nor S. aureus induced proliferation of memory
Th17 cells (Figure 4B). In contrast to the proliferation in IL-17+
cells, we observed only minimal proliferation of Th1 (CD4+
IFN-g+) cells to K. pneumoniae serotypes, Escherichia coli,
S. pneumoniae, or Staphylococcus aureus, and there was no
striking difference between bacterial species (Figure S3B).
E. coli, another member of the Enterobacteriaceae family,
induced a level of Th17 proliferation that was notable but not
as significant as the proliferation in the K. pneumoniae strains
(Figure 4B).
To determine whether the serotype-independent Th17 cell
response induced with mucosal immunization confers protec-
tion against heterologous K. pneumoniae serotypes, we immu-
nized mice with K. pneumoniae-43816 (ATCC) (serotype K2)
and challenged them with either K. pneumoniae-303 (serotype
K16), K. pneumoniae-396 (serotype K1), or the recently isolated
K. pneumoniae-NMD1+ strain. Despite lacking serotype-specific
antibodies, all of the challenged mice were protected from
heterologous serotypes (Figures 4C–4E). To further exclude
a role of antibodies, we performed immunization with
K. pneumoniae-43816 (ATCC) (serotype K2) followed by a heter-
ologous challenge with K. pneumoniae-396 (serotype K1) in
Ighm/ mice. As shown in Figure 4F, immunization of Ighm/
mice with this K2 serotype provided significant protection
against the highly virulent K. pneumoniae-396 (serotype K1)
strain. Expression of Il17a and Il17f mRNA as well as IL-17
protein were upregulated in the lung during this heterologous
challenge (Figure 4G and Figure S3C), suggesting a critical role
for Th17 cells. Furthermore, IL-17 neutralizing antibody signifi-
cantly attenuated vaccine efficacy (Figure 4F) in this heterolo-
gous challenge model. To confirm that Th17 cells, not B cells,
confer crossprotection, cells were sorted from IL-17F-Thy1.1
reporter mice immunized with K. pneumoniae-43816 (ATCC)d mediastinal lymph nodes.
terisk (*) denotes significantly higher cell numbers compared to the numbers in
unity 35, 997–1009, December 23, 2011 ª2011 Elsevier Inc. 1001
Figure 3. Mucosal Immunity to an Autologous Bacterial Challenge Is Mediated by B Cells and Th17 Cells
(A) C57BL/6 mice were immunized intranasally with 20 mg of heat-killed K. pneumoniae-43816 (ATCC) (serotype K2) at day 0 and day 7. Four weeks after the 2nd
immunization, immunized mice and naive unimmunized mice were infected with 104 live K. pneumoniae-43816 (ATCC) (serotype K2) and sacrificed 24 hr later.
Lung burden and systemic dissemination were determined by lung (left panel) and spleen (right panel) CFUs. Each group has an n > 20 from four independent
experiments. Data represent the mean ± SD of each group.
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One week after transfer, mice were challenged with the virulent
K. pneumoniae-396 (serotype K1) strain. Notably, mice receiving
the Th17 cell transfer, but not CD19+ B cells, had a significantly
reduced lung burden (Figure 4H).
Cross-Serotype Protection in Heterologous Challenge
Is Independent of Interferon-g
To investigate the role of Th1 cells in cross-serotype protection,
Ifng/ and age-matched wild-type mice were immunized with
K. pneumoniae-43816 (ATCC) (serotype K2) and challenged
with K. pneumoniae-396 (serotype K1). We observed equal
protection in wild-type and Ifng/ mice (Figure 5A), demon-
strating that IFN-g is dispensable for this response. To determine
the role of Th17 and Th1 cells more specifically, flow cytometry
sorted Th17 and Th-non-17F (which contains Th1 cells) were
adoptively transferred into Rag2/Il2rg/mice. Only the trans-
fer of Th17 cells provided protection whenmice were challenged
with the heterologous K. pneumoniae-396 (serotype K1) strain
4 weeks later (Figure 5B). To confirm the role of IL-17 signaling
in the heterologous challenge, Rag2/ mice receiving adop-
tively transferred Th17 cells were administered IL-17RC neu-
tralizing antibody or IFN-g neutralizing antibody after a
K. pneumoniae-396 (serotype K1) challenge. Blocking IL-17RC
signaling by anti-IL17RC, but not blocking IFN-g, abolished the
protection conferred by the adoptively transferred cells (Fig-
ure 5C), demonstrating that IL-17 from Th17 cells are key for
cross-serotype protection. To investigate the potential role of
IFN-g in the absence of IL-17RA signaling and B cell-mediated
immunity, K. pneumoniae-43816 (ATCC) (serotype K2)-immu-
nized Il17ra/ mice with B cell depletion were challenged with
K. pneumoniae-396 (serotype K1) with or without anti-IFN-g.
Blockade of IFN-g did not make the mice more susceptible to
K. pneumoniae-396 (serotype K1) challenge even when
IL-17RA signaling was absent (Figure 5D).
Th17 Cells Recognize OMPs
To explore the mechanism of this Th17 cell-mediated, clade-
specific, serotype-independent protection, we sought to deter-
mine which antigen(s) these Th17 cells respond to. We hypothe-(B) Four weeks after the 2nd immunization, immunized mice and naive mice were in
24 hr later. A group of immunized mice also received intraperitoneal injection (i.p
received neutralizing antibody against IL-17A and/or IL-22 i.t. immediately prior
spleen CFU (middle panel) and neutrophil recruitment was determined by flow cy
(C) Rag2/Il2rg/ mice were immunized intranasally with 20 mg K. pneumonia
immunization, immunized mice and naive unimmunized mice were infected with
Lung burden and systemic dissemination were determined by lung (left panel) an
(D) C57BL/6 mice were immunized intranasally with 20 mg heat-killed K. pneumo
immunization, immunized mice and naive unimmunized mice were infected with
Anti-K. pneumoniae-43816 (ATCC) (serotype K2) IgG and IgA in the serum and
immunized mice were measured by ELISA.
(E) C57BL/6micewere immunized intranasally with 20 mg heat-killedK. pneumonia
cytometry sorted B220+ cells from immunized mice lungs were adoptively transfe
from immunized mice were infected with 104 live K. pneumoniae-43816 (ATCC) (s
were determined by lung (left panel) and spleen (right panel) CFUs. Each group h
(F) Ighm/ mice were immunized intranasally with 20 mg heat-killed K. pneumon
immunization, immunized Ighm/ mice and naive unimmunized Ighm/ mice
sacrificed 24 hr later. A group of immunizedmice also received i.p. rat IgG or 1A8 2
antibody against IL-17A i.t. immediately prior to infection. Bacterial burden was d
two independent experiments with two to four mice in each group and represen
Immsized that OMPs might be a potential candidate and isolated
them by ultracentrifugation from the K. pneumoniae-43816
(ATCC) (serotype K2) vaccine strain to stimulate carboxyfluores-
cein diacetate, succinimidyl ester (CFSE)-labeled mediastinal
lymph nodes cells from immunized mice. Th17 cells responded
to K. pneumoniae-43816 (ATCC) (serotype K2)-OMP but not
recombinant E. coli OmpA (EC-OMP), confirming the antigen
specificity of the Th17 cells induced by immunization (Fig-
ure S4A). To test the crossreactivity of Th17 cells to
K. pneumoniae strains with different serotypes, we isolated
OMPs from various serotypes of K. pneumoniae, including K.
pneumoniae-43816 (ATCC) (serotype K2), K. pneumoniae-396
(serotype K1), and K. pneumoniae-NMD1+. Interestingly, when
these OMPs were added to the culture of CFSE-labeled lymph
nodes cells from immunized mice, they all induced robust Th17
proliferation comparable to the OMPs isolated from the immuni-
zation strain (K. pneumoniae-43816 (ATCC) (serotype K2) (Fig-
ure S4B), further supporting that immunization-induced Th17
cells are clade specific and serotype independent. To confirm
the Th17 cell proliferation is OMP specific, we restimulated the
Th17 cells from mediastinal lymph nodes with OMPs in the
presence of wild-type or major histocompatibility complex
(MHC)-II-deficient dendritic cells. Although Th17 cells cultured
with wild-type dendritic cells (DCs) responded to autologous
and heterologous OMPs (Figure 6A, upper panel), Th17 cells
cultured with MHC-II-deficient DCs, which are deficient in
antigen presentation, had significantly reduced proliferative
responses to OMP antigens (Figure 6A, lower panel), demon-
strating that OMP-induced Th17 cell proliferation is at least
partially MHC-II dependent. Cytokine analysis of the tissue
culture supernatant revealed that MHC-II-independent Th17
cell proliferation could be a result of IL-1b produced by DCs
regardless ofMHC-II expression (Figure 6B). These observations
led us to hypothesize that immunization with OMPs together with
an adjuvant may confer the same level of protection as observed
in the animals immunized with heat-killed bacteria. We immu-
nized mice intranasally with lipopolysaccharides (LPS) (as a TLR4
adjuvant) with or without OMPs isolated from K. pneumoniae-
43816 (ATCC) (serotype K2). Seven days later, OMPs with LPS
adjuvant induced robust Th17 but not Th1 responses in the lungsfected with 104 live K. pneumoniae-43816 (ATCC) (serotype K2) and sacrificed
.) rat IgG or 1A8 24 hr and 2 hr prior to infection. A group of immunized mice
to infection. Bacterial burdens were determined by lung CFU (left panel) and
tometry on bronchoalveolar lavage cells (right panel). Each group has an n = 5.
e-43816 (ATCC) (serotype K2) at day 0 and day 7. Four weeks after the 2nd
104 live K. pneumoniae-43816 (ATCC) (serotype K2) and sacrificed 24 hr later.
d spleen (right panel) CFUs. Each group has four to five mice.
niae-43816 (ATCC) (serotype K2) at day 0 and day 7. Four weeks after the 2nd
104 live K. pneumoniae-43816 (ATCC) (serotype K2) and sacrificed 24 hr later.
lung homogenate from naive uninfected and naive infected unimmunized and
e-43816 (ATCC) (serotype K2) at day 0 and day 7 and sacrificed on day14. Flow
rred into Rag2/Il2rg/mice. Rag2/Il2rg/mice receiving PBS or B cells
erotype K2) and sacrificed 24 hr later. Lung burden and systemic dissemination
as n =4 mice.
iae-43816 (ATCC) (serotype K2) at day 0 and day 7. Four weeks after the 2nd
were infected with 104 live K. pneumoniae-43816 (ATCC) (serotype K2) and
4 hr and 2 hr prior to infection. A group of immunizedmice received neutralizing
etermined by lung CFU (left panel) and spleen CFU (right panel). Data are from
t the mean ± SD of each group.
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Figure 4. Cross-Serotype Protection with Heterologous Bacterial Challenge Requires Th17 Cells, Not B Cells
(A) Various stains of heat-killed K. pneumoniae were coated on an ELISA plate, and lung homogenate from naive mice (labeled as N) and K. pneumoniae-43816
(ATCC) (serotype K2)-immunized mice (labeled as V) was tested for crossreactivity. K. pneumoniae strain numbers and serotypes are also listed.
(B) Mediastinal lymph nodes from immunized C57BL/6 mice were labeled with CFSE and cultured with different serotypes of heat-killed K. pneumoniae, E. coli,
S. aureus, and S. pneumoniae for 3 days. Proliferation of IL-17+ cells was analyzed by intracellular IL-17 staining and CFSE dilution. C57BL/6 mice were
immunized intranasally with 20 mg heat-killed K. pneumoniae-43816 (ATCC) (serotype K2) at day 0 and day 7.
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Th17 Cells and Clade-Specific Immunity(Figures 6C and 6D). Importantly, these animals were protected
against a heterologous challenge with live K. pneumoniae-396
(serotype K1) (Figure 6E). To further clarify the specific role of
Th17 cells, we did a heterologous challenge in Ighm/ mice.
Again, IL-17RC blockade in K. pneumoniae-43816 (ATCC) (sero-
type K2)-immunized Ighm/ mice completely abrogated the
protection to a K. pneumoniae-396 (serotype K1) heterologous
challenge (Figure 6F), confirming the crucial role of IL-17RC
signaling in OMP-induced cross-serotype protection.
DISSCUSSION
The involvement of Th17 cells in protective vaccination
against intracellular pathogens has been previously documented
(Khader et al., 2007). In this model, IL-17 was required for the
induction of CXCR3 ligands that regulated the recruitment of
Th1 cells that controlled the growth of the pathogen. However,
there is a relative lack of evidence that memory Th17 cells
mediate direct protection in an antigen-specific manner. Our
data demonstrate that instead of recruiting other subsets of
T helper cells by orchestrating chemokine gradients as in the
Mycobacterium tuberculosis model, Th17 cells can be primed
by mucosal immunization and respond to secondary stimulation
with either whole bacterial lysates in an antigen-dependent
manner or to purified OMPs from both vaccine and challenge
strains of K. pneumoniae. Approximately 50%of this latter prolif-
erative response was MHC II-dependent; however, there was
also significant ex vivo proliferation when sorted CD4+ T cells
were cultured with class II MHC-deficient antigen presenting
cells. The MHC-II-independent Th17 proliferation may be driven
by IL-1b. We were also able to detect some soluble IL-1b in
S. aureus and S. pneumoniae cultures (data not shown), yet
we did not observe significant Th17 cell proliferation to these
antigens after K. pneumoniae vaccination. However, in these
cultures, we used bulk mediastinal LN cells and Th17 frequen-
cies are lower compared to theOMPMHC-II-deficient DC exper-
iments. These latter experiments used flow cytometry-sorted
purified CD4+ T cells. Thus one possibility that we did not detect
any proliferating Th17 cells in S. aureus and S. pneumonia is that
the precursor frequency of IL-1b responsive cells was lower.
Importantly, these proliferating Th17 cells were able to confer
protection to several heterologous serotypes of K. pneumoniae
including NDM-1, and that protection to the most virulent
K. pneumoniae-396 (serotype K1) strain was dependent on
IL-17A and IL-17RC and was independent of IFN-g.
Recently, Wu¨thrich et al. have also shown that vaccine-
induced IL-17+ cells can also mediate protection against pulmo-(C–E) Ten days after the 2nd immunization, immunized mice and naive unimm
K. pneumoniae-396 (serotype K1) (D), or K. pneumoniae-NDM1+ (serotype unknow
determined by lung (left panel) and spleen (right panel) CFUs. Each groups has fo
killed K. pneumoniae-43816 (ATCC) (serotype K2) at day 0 and day 7. Four week
Ighm/ mice were infected with 104 live K. pneumoniae-396 (serotype K1) and s
antibody against IL-17A right before infection.
Bacterial burden was determined by lung CFU (left panel) and spleen (right panel)
two independent experiments with three to four mice each group.
(H) IL-17F-Thy1.1 reporter mice were immunized with heat-killed K. pneumoniae-
were prepared and stainedwith CD4 and Thy1.1. Flow-cytometry-sorted 105 Th17
intravenously transferred to Rag2/mice. Four weeks after transfer, mice were in
burdens were assessed by CFU. Each group has n = 5. Data represent the mea
Immnary infection with Coccidioides posadasii, Histoplasma capsu-
latum, and Blastomyces dermatitidis (Wu¨thrich et al., 2011a).
This same group has recently made a blastomyces-specific
CD4+ TCR receptor transgenic mouse line and interestingly the
transgenic CD4+ T cells proliferate in response to several dimor-
phic fungi (Wu¨thrich et al., 2011b). These data suggest that
T cells can have broad specificity and recognize clades of organ-
isms. Consistent with this, a recent analysis of Mycobacterium
tuberculosis antigens showed that human T cell epitopes of
Mycobacterium tuberculosis are strongly evolutionarily con-
served (Comas et al., 2010). Moreover, Malley and colleagues
(Lu et al., 2008) have shown that vaccination with S. pneumoniae
cell wall polysaccharide elicits IL-17 from CD4+ T cells, and this
response is required to eradicate S. pneumoniae colonization in
the mouse. In follow-up work, this group has identified a number
of S. pneumoniae antigens that can induce Th17 responses in
whole-cell antigen-immunizedmice (Moffitt et al., 2011).Our study
shows that immunization-induced Th17 cells provide serotype-
independent protection to another important encapsulated
bacteria, K. pneumoniae. Moreover protection still occurred in
B cell-deficient (Ighm/) mice. Taken together, these data indi-
cate that one theoretical evolutionary advantage of Th17 cells as
opposed to non-CD4+ T cell sources of IL-17 is that they can
provide protection to the host when antibody responses are
compromised or restricted to the capsular serotype. These data
also suggest that Th17-based vaccines can be designed for
immunocompromised patients that may lack B cell responses or
for patients undergoing anti-CD20 treatment.
In the setting of K. pneumoniae, one group of antigens that are
sufficient to induce heterologous Th17-mediated protection
independent of capsular serotype are OMPs. Our data demon-
strate that OMPs from Klebsiella in conjunction with LPS (an
experimental adjuvant that activates TLR4) generated a Th17
response comparable to the whole lysate. Safety is a paramount
concern in vaccine development and translating these studies
to potential clinical use would require additional testing of
adjuvants such as monophosphoryl lipid A.
Taken together, we provide strong evidence that an evolu-
tionary advantage of Th17 cells is to provide clade-specific
immunity that is independent of capsular serotype. Many impor-
tant human bacterial pathogens are encapsulated organisms,
such as S. pneumoniae and K. pneumoniae. Because polysac-
charide capsules can avoid nonopsonic phagocytosis, success-
ful vaccination against these bacteria requires polyvalent
vaccines consisting of the most lethal serotypes (Weinberger
et al., 2010; Malley, 2010; Ovodov, 2006). To successfully
coevolve with these pathogens, mammals needed to acquireunized mice were infected with 104 K. pneumoniae-303 (serotype K16) (C),
n) (E) and sacrificed 24 hr later. Lung burden and systemic dissemination were
ur to five mice. (F) Ighm/mice were immunized intranasally with 20 mg heat-
s after the 2nd immunization, immunized Ighm/mice and naive unimmunized
acrificed 24 hr later. A group of immunized mice also received i.t. neutralizing
CFUs. Th17 responses in the lung were analyzed by RT-PCR (G). Data are from
43816 (ATCC) (serotype K2) and were sacrificed 1 week later. Lung single cells
(CD4+Thy1.1+) permouse or 105 B cells (CD19+CD4Thy1.1) per mousewere
fected with 104 K. pneumoniae-396 (serotype K1) and sacrificed at 24 hr. Lung
n ± SD of each group.
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Figure 5. Cross-Serotype Protection in Heterologous Challenge Is Mediated by Th17 not Th1
(A) C57BL/6 and Ifng/mice were immunized intranasally with 20 mg heat-killed K. pneumoniae-43816 (ATCC) (serotype K2) at day 0 and day 7. Twenty-eight
days after the 2nd immunization, immunizedmice and naive unimmunizedmicewere infectedwith 104K. pneumoniae-396 (serotype K1) and sacrificed 24 hr later.
Lung burden and systemic dissemination were determined by lung (left panel) and spleen (right panel) CFUs. Each group has four to five mice.
(B) IL-17F-Thy1.1 reporter mice were immunized with heat-killed K. pneumoniae-43816 (ATCC) (serotype K2) and were sacrificed 1 week later. Lung single cells
were prepared and stained with CD4 and Thy1.1. Flow-cytometry-sorted 105 Th17 (CD4+Thy1.1+) per mouse or 105 Th-non17F (CD4+Thy1.1-) per mouse was
intravenously transferred to Rag2/Il2rg/ mice. Four weeks after transfer, mice were infected with 104 K. pneumoniae-396 (serotype K1) and sacrificed at
24 hr. Lung burdens were assessed by CFU. Each group has three to four mice.
(C) IL-17F-Thy1.1 reporter mice were immunized with heat-killed K. pneumoniae-43816 (ATCC) (serotype K2) and were sacrificed 1 week later. Lung single cells
were prepared and stained with CD4 and Thy1.1. flow-cytometry -orted 105 Th17 (CD4+Thy1.1+) per mousewere intravenously transferred toRag2/mice. Four
weeks after transfer, mice were infected with 104K. pneumoniae-396 (serotype K1). Control IgG, a-IL17RC or a-IFN-gwere given i.t. 12 hr after infection andmice
were sacrificed at 24 hr after infection. Lung and spleen burdens were assessed by CFU. Each group has four mice.
(D) Il17ra/ mice with B cell depletion (0.1 mg anti-CD20 i.p. weekly) mice were immunized intranasally with 20 mg heat-killed K. pneumoniae-43816 (ATCC)
(serotype K2) at day 0 and challenge with 104 K. pneumoniae-396 (serotype K1) on day 28. Control IgG or a-IFN-g were given i.t. 12 hr after infection and mice
were sacrificed at 24 hr after infection. Lung bacterial burdens were assessed by CFU. Each group has four to five mice.
Data represent the mean ± SD of each group.
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Th17 Cells and Clade-Specific Immunityhost resistance mechanisms. A limitation of humoral immunity is
its specificity to the serotype of the infecting strain. However, as
demonstrated here, the induction ofmucosal Th17 cells provides
a broader resistance mechanism than antibodies. We postulate
that this may be very important in the gastrointestinal tract,
where mucosal Th17 responses must deal with diverse clades
of organisms. Although memory Th17 cells have been shown
to be short lived in response to an intracellular pathogen such
as Listeria monocytogenes (Pepper et al., 2010), we observed
significant Th17 memory populations 4 weeks after immuniza-
tion. In the mediastinal lymph nodes, Th17 cells are CD127hi
CD69loCD44hiCD25lo CD62Llo, resembling an effector memory
phenotype. Moreover, many extracellular pathogens in humans
also colonize mucosal surfaces and thus prolonged or recurrent
antigen exposure may play a role in maintaining memory Th17
responses. Our data show that approaches to induce mucosal1006 Immunity 35, 997–1009, December 23, 2011 ª2011 Elsevier IncTh17 cells will be an effective means of vaccination against
organisms with multiple capsular serotypes. However, this
broader specificity may also be why Th17 cells have been linked
to autoimmunity, and one would need to screen vaccine anti-
gens carefully to avoid this caveat. In closing, we believe these
data provide an explanation of why IL-17 has evolved to be
expressed in CD4 T cells, and this evolutionary advantage can
be exploited for improved vaccination strategies.
EXPERIMENTAL PROCEDURES
Immunization and Infection
Twenty micrograms heat-killed K. pneumoniae-43816 (ATCC) (serotype K2)
was given to isoflurane anesthetized mice in sterile PBS (40 ml) intranasally
once or twice as indicated. Mice were then infected with 104 live
K. pneumoniae by oropharyngeal aspiration-tongue pull technique (referred
as i.t.) and sacrificed at 24 hr after infection. Bacterial burden in the lung and.
Figure 6. The Th17 Response to Klebsiella OMPs Is Partially MHC-II Dependent
(A) flow cytometry sorted CD4 T cells from K. pneumoniae-43816 (ATCC) (serotype K2)-immunized mice mediastinal lymph nodes were labeled with CFSE and
cultured with flow cytometry sorted CD11+ DCs from C57BL/6 or MHC-II KO spleen for 4 days in the presence or absence of 10 ml/ml OMP from K. pneumoniae-
396 (serotype K1) or K. pneumoniae-43816 (ATCC) (serotype K2). Th17 proliferation was measure by intracellular IL-17 staining and CFSE dilution. Data are
representative from two independent experiments.
(B) IL-1b levels in the culture supernatants were measured by Luminex.
(C) C57BL/6 mice were immunized with heat-killed K. pneumoniae-43816 (ATCC) (serotype K2) (labeled as HKKP) or 1 mg LPS or 1 mg LPS plus 10 mg OMPs
isolated from K. pneumoniae-43816 (ATCC) (serotype K2). Seven days later, mice were sacrificed and lungs were harvested for intracellular IL-17 and IFN-g
analysis on gated CD4+ T cells by flow cytometry.
(D) Total Th1 (CD4+IFN-g+) and Th17 (CD4+IL-17+) cells were graphed.
(E) Four weeks after immunization, LPS or LPS+OMP-immunized mice were challenged with 104 live K. pneumoniae-396 (serotype K1), bacterial burden was
determine by lung and spleen CFU. Data are from two independent experiments with three to five mice in each group.
(F) Ighm/mice were immunized with 10 mg OMP isolated from K. pneumoniae-43816 (ATCC) (serotype K2) and challenged with K. pneumoniae-396 (serotype
K1) 4 weeks later. Control IgG or anti-IL17RCwas given i.t. 12 hr after infection. Mice were sacrificed at 24 hr, and bacterial burden was determined by lung CFU.
Each group has five mice.
Data represent the mean ± SD of each group.
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Th17 Cells and Clade-Specific Immunityspleen were analyzed by CFU on the homogenates. Lung homogenates were
then centrifuged, supernatant was used for Luminex analysis, and pellets were
lysed in TRIzol for RNA extraction.
Mice and Intratracheal Administrations
C57BL/6 (B6), Ifng/ Ighm/ mice were purchased from the Jackson Labo-
ratory. Rag2/ and Rag2/Il2rg/ mice were purchased from Taconic
Farm. IL-17F-Thy1.1 reporter mice have been previously described (Lee
et al., 2009); 104 K. pneumoniae were given to isoflurane anesthetized mice
in sterile PBS (50 ml) by i.t. Il17ra/mice on the B6 background were provided
by Amgen. All procedures were performed according to the Louisiana State
University Health Sciences Center Institutional Animal Care and Use
Committee guidelines (protocol 2660).
Experimental K. pneumoniae Infection
K. pneumoniae ATCC strain 43816, serotype 2, BAA-2146 (NDM1+) (ATCC) or
clinical isolates were grown in 100 ml of tryptic soy broth (Difco) for 18 hr at
37C. The quantity of 1 ml of the culture was added to 100 ml of fresh tryptic
soy broth and grown for 2 hr, allowing the culture to reach early log phase. The
concentration of K. pneumoniae was determined by measuring the absor-
bance at 600 nm. A standard curve of absorbance units based on known
CFUs was used to calculate inoculum concentration. Bacteria were pelleted
by centrifugation at 5,000 rpm for 15 min, washed twice in PBS, and resus-
pended at the desired concentration. Twenty-four hours after infection, mice
were sacrificed and left lungs were harvested in medium with serum for flow
cytometry analysis or in TriZol for RNA extraction, right lungs were harvested
in sterile PBS for CFU and Luminex (Millipore) on the Bioplex reader (Bio-Rad).
In some experiments 0.1 mg/mouse anti-IL17RC (R&D Systems) or 0.1 mg/
mouse anti-IFNg XMG1.2 (eBioscience) were administered i.t. 12 hr after
bacterial challenge.
Isolation of Murine Lung Single Cells for ICS
Lungs were isolated and minced with forceps and small scissors and digested
with 1–2 mg/ml collagenase (Sigma) for 90 min at 37C. Digested tissue was
passed through a sterile 70 mm filter (BD Falcon) to get a single-cell suspen-
sion. After washing, the cells are ready for flow cytometry or in vitro stimulation.
Flow Cytometry Analysis
Single cells from mice lungs were stimulated for 5–6 hr with 50 ng/ml PMA
(Sigma) and 750 ng/ml ionomycin (Sigma). After 1 hr, 1 ml/ml GolgiStop (BD
PharMingen) was added to block cytokine secretion. Cells were surface
stained for 15–30 min at 4C with anti-Thy1.1, anti-CD4 mAb (RM45; BD
PharMingen), and GL3 (eBioscience) in PBS supplemented with 1% BSA
and 0.2% sodium azide. Cells were then fixed and permeabilized with
Cytofix/Cytoperm (BD PharMingen) and stained intracellularly with anti-
IL-17, anti-IL-22 and anti-IFNg (XMG1.2) (eBioscience). Samples were
acquired on a flow cytometryAria or LSR-II flow cytometer and data analysis
was conducted with FlowJo software (Treestar).
Gene-Expression Assays
Gene expression was measured by real-time RT-PCR with premade primers
and probes from ABI Biosystems. Briefly, total lung tissue was harvested
and total RNA was extracted with TRIzol (Invitrogen). First-strand cDNA was
synthesized with BioRad iScript kit. cDNA was then used for real-time PCR
on a Bio-Rad CFX96 thermal cycler and fold changes were calculated by the
delta-delta Ct method.
Statistical Analyses
Unpaired, two-tailed, Student’s t tests, m = 0.05, were used to assess whether
the means of two normally distributed groups differed significantly. One-way
analysis of variance was used to compare multiple means. Significance is indi-
cated as p < 0.05, p < 0.01, and p < 0.001. All error bars represent the standard
deviation (SD).
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